Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
BMC Cancer|September 2, 2020
Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical studyLucheng Zhu, Zhizheng Xu, Yajun Wu, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2020
The survival benefit of radiotherapy in localized primary adult rhabdomyosarcomaRuping Zhao, Xiaoli Yu, Yan Feng, et al.
Oncotarget|November 10, 2016
Dietary fibre intake and risk of breast cancer: A systematic review and meta-analysis of epidemiological studiesSumei Chen, Yuanyuan Chen, Shenglin Ma, et al.
Journal of Thoracic Disease|February 13, 2019
Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapyKan Wu, Xiao Xu, Xiadong Li, et al.
Oncotarget|March 10, 2015
Autophagy protects against dasatinib-induced hepatotoxicity via p38 signalingXiaochun Yang, Jincheng Wang, Jiabin Dai, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 23, 2023
Cancer-associated fibroblasts facilitate DNA damage repair by promoting the glycolysis in non-small cell lung cancerHongfang Zhang, Ke Zhang, Liqing Qiu, et al.
Anti-Cancer Drugs|October 2, 2008
Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancerHaijun Zhong, Yiping Zhang, Shenglin Ma, et al.
Molecular Medicine Reports|September 17, 2019
Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathwayLi Yuan, Mengmeng Zhou, Dawei Huang, et al.
Molecular Medicine Reports|October 12, 2022
[Corrigendum] Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathwayLi Yuan, Mengmeng Zhou, Dawei Huang, et al.
Experimental and Therapeutic Medicine|December 16, 2015
Use of a correlation analysis model in the optimization of intensity-modulated radiotherapy of prostate cancerXiadong Li, Qinghua Deng, Shenglin Ma, et al.
Pageof 22